Related references
Note: Only part of the references are listed.Stable Chitosan-Based Nanoparticles Using Polyphosphoric Acid or Hexametaphosphate for Tandem Ionotropic/Covalent Crosslinking and Subsequent Investigation as Novel Vehicles for Drug Delivery
Ramzi Mukred Saeed et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial
Greg J. Fox et al.
BMJ OPEN (2020)
Pharmacokinetics and in vivo distribution of optimized PLGA nanoparticles for pulmonary delivery of levofloxacin
Sunny R. Shah et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
Development and evaluation of nanoemulsion and microsuspension formulations of curcuminoids for lung delivery with a novel approach to understanding the aerosol performance of nanoparticles
Yuosef Al Ayoub et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Potential of Chitosan and its derivatives for controlled drug release applications - A review
Rizwan Safdar et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)
New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease
Simon F. K. Lee et al.
CURRENT OPINION IN PULMONARY MEDICINE (2019)
Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment
Ludmylla Cunha et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)
Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB
Gavin J. Churchyard et al.
PLOS MEDICINE (2019)
A study on the preparation of chitosan-tripolyphosphate nanoparticles and its entrapment mechanism for egg white derived peptides
Zhiyang Du et al.
FOOD CHEMISTRY (2019)
Application of multiple regression analysis in optimization of metronidazole-chitosan nanoparticles
Hazem Abdul Kader Sabbagh et al.
JOURNAL OF POLYMER RESEARCH (2019)
Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system
Parijat Pandey et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Parameters influencing the size of chitosan-TPP nano- and microparticles
Sruthi Sreekumar et al.
SCIENTIFIC REPORTS (2018)
Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline
Tejal Rawal et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future
Piyush Mehta et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis
Tejal Rawal et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2017)
An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial
Tara C. Bouton et al.
TRIALS (2017)
Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model
Emily A. Kendall et al.
PLOS MEDICINE (2017)
Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis
Tejal Rawal et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Design, Optimization, and Evaluation of Lurasidone Hydrochloride Nanocrystals
Sunny Shah et al.
AAPS PHARMSCITECH (2016)
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
Alexander S. Pym et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis
Tarun Garg et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2016)
The formulation of nanomedicines for treating tuberculosis
Ana Costa et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Dry powder inhalable formulations for anti-tubercular therapy
Thaigarajan Parumasivam et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Preparation of chitosan-TPP sub-micron particles: Critical evaluation and derived recommendations
Filip Razga et al.
CARBOHYDRATE POLYMERS (2016)
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
Nazila Kamaly et al.
CHEMICAL REVIEWS (2016)
Pulmonary pharmacokinetics of levofloxacin in rats after aerosolization of immediate-release chitosan or sustained-release PLGA microspheres
Marisa C. Gaspar et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Chitosan-tripolyphosphate nanoparticles: Optimization of formulation parameters for improving process yield at a novel pH using artificial neural networks
Rania A. Hashad et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin
Rohan V. Pai et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2016)
Preparation, Characterization and in Vivo Antimycobacterial Studies of Panchovillin-Chitosan Nanocomposites
Edward Rwegasila et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods
T. Cerchiara et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder
John G. Y. Chan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Development and Characterization of Nanoembedded Microparticles for Pulmonary Delivery of Antitubercular Drugs against Experimental Tuberculosis
Amit Kumar Goyal et al.
MOLECULAR PHARMACEUTICS (2015)
Dry powder inhalers and the right things to remember: a concept review
Roberto W. Dal Negro
MULTIDISCIPLINARY RESPIRATORY MEDICINE (2015)
Preparation of chitosan–TPP nanoparticles and their physical and biological properties
Eunsun Lee et al.
Asian Journal of Pharmaceutical Sciences (2015)
Glibenclamide Nanocrystals for Bioavailability Enhancement: Formulation Design, Process Optimization, and Pharmacodynamic Evaluation
Sunny R. Shah et al.
JOURNAL OF PHARMACEUTICAL INNOVATION (2014)
Phase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder Capreomycin: a New Approach to Therapy of Drug-Resistant Tuberculosis
Ashwin S. Dharmadhikari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
Vija Skripconoka et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Devices and formulations for pulmonary vaccination
Wouter F. Tonnis et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(DL-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid
L. L. I. J. Booysen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Application of Plackett-Burman screening design for preparing glibenclamide nanoparticles for dissolution enhancement
Sunny R. Shah et al.
POWDER TECHNOLOGY (2013)
Challenges with Developing In Vitro Dissolution Tests for Orally Inhaled Products (OIPs)
Trevor Riley et al.
AAPS PHARMSCITECH (2012)
Optimization, in vitro-in vivo evaluation, and short-term tolerability of novel levofloxacin-loaded PLGA nanoparticle formulation
Gaurav Kumar et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Development of chitosan-based nanoparticles for pulmonary delivery of itraconazole as dry powder formulation
Somayeh Jafarinejad et al.
POWDER TECHNOLOGY (2012)
Phagostimulatory effect of uptake of PLGA microspheres loaded with rifampicin on alveolar macrophages
Keiji Hirota et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2011)
Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid
Pejman Sadegh Pourshahab et al.
JOURNAL OF MICROENCAPSULATION (2011)
Cellular targeting and trafficking of drug delivery systems for the prevention and treatment of MTb
C. Lawlor et al.
TUBERCULOSIS (2011)
An Improved Formulation Screening and Optimization Method Applied to the Development of a Self-Microemulsifying Drug Delivery System
Ying Liu et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2010)
The potential of chitosan for pulmonary drug delivery
A. Grenha et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2010)
Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis
Awadh B. Yadav et al.
TUBERCULOSIS (2010)
Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins
Ana Grenha et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers
Wei Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins
Bing Hu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
Chitosan nanoparticle as protein delivery carrier - Systematic examination of fabrication conditions for efficient loading and release
Quan Gan et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2007)
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
SA Agnihotri et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis
A Sharma et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Share Paper
